Opinion
Video
Biological Mechanisms of GIST Resistance and Tumor Heterogeneity
Author(s):
Experts discuss the biological mechanisms of resistance in gastrointestinal stromal tumors (GIST), differentiating between primary and secondary resistance, and explore how tumor heterogeneity evolves throughout treatment, with implications for long-term management and treatment strategies.
Video content above is prompted by the following:
- Let’s start with the fundamentals of resistance in GIST. Could you explain the biological mechanisms of resistance in GIST? Could you differentiate between primary and secondary resistance in GIST and explain how each impacts your treatment approach?
- How does tumor heterogeneity evolve throughout treatment course, and what implications does this have for long-term management?
Latest CME
View All
Video
Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | North Carolina
May 2nd 2025 - Jun 7th 2025
online-activity
Video
Community Oncology Connections™: Navigating Early-Stage HR+/HER2- Breast Cancer – Clinical Developments and Innovative Treatments | Kansas
May 1st 2025 - Jun 6th 2025
online-activity
Video
From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment
May 1st 2025 - May 2nd 2026
online-activity
Related Content
.png?fit=crop&auto=format)
